BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qing-Fang Han, Wen-Jia Li, Kai-Shun Hu, Jie Gao, Wen-Long Zhai, Jing-Hua Yang, Shui-Jun Zhang. Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer. Mol Cancer 2022;21:207. [PMID: 36320056 DOI: 10.1186/s12943-022-01671-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Peng W, Bai S, Zheng M, Chen W, Li Y, Yang Y, Zhao Y, Xiong S, Wang R, Cheng B. An exosome-related lncRNA signature correlates with prognosis, immune microenvironment, and therapeutic responses in hepatocellular carcinoma. Transl Oncol 2023;31:101651. [PMID: 36933293 DOI: 10.1016/j.tranon.2023.101651] [Reference Citation Analysis]
2 Gondaliya P, Sayyed AA, Driscoll J, Patel K, Patel T. Extracellular vesicle RNA signaling in the liver tumor microenvironment. Cancer Lett 2023;558:216089. [PMID: 36758739 DOI: 10.1016/j.canlet.2023.216089] [Reference Citation Analysis]
3 Mardi N, Salahpour-Anarjan F, Nemati M, Shahsavari Baher N, Rahbarghazi R, Zarebkohan A. Exosomes; multifaceted nanoplatform for targeting brain cancers. Cancer Lett 2023;557:216077. [PMID: 36731592 DOI: 10.1016/j.canlet.2023.216077] [Reference Citation Analysis]
4 Sen S, Xavier J, Kumar N, Ahmad MZ, Ranjan OP. Exosomes as natural nanocarrier-based drug delivery system: recent insights and future perspectives. 3 Biotech 2023;13:101. [PMID: 36860361 DOI: 10.1007/s13205-023-03521-2] [Reference Citation Analysis]
5 Liu Z, Zhang N, Xin B, Shi Y, Liang Z, Wan Y, Hu X. Exosomes from LSD1 knockdown breast cancer cells activate osteoclastogenesis and inhibit osteoblastogenesis. Int J Biol Macromol 2023;235:123792. [PMID: 36828097 DOI: 10.1016/j.ijbiomac.2023.123792] [Reference Citation Analysis]
6 Zheng W, Zhu T, Tang L, Li Z, Jiang G, Huang X. Inhalable CAR-T Cell-Derived Exosomes as Paclitaxel Carriers for Treating Lung Cancer.. [DOI: 10.21203/rs.3.rs-2494599/v1] [Reference Citation Analysis]
7 Liu L, Huang Y, Wang Q, Zhao X, Feng Y, Fang Z, Qiao Y, Li S. Exosomal miR-216a-5p targeting TLR-4 alleviates liver ischemia-reperfusion injury by regulating M2 macrophage polarization and neutrophil inflammation.. [DOI: 10.21203/rs.3.rs-2439073/v1] [Reference Citation Analysis]
8 Matsuzaka Y, Yashiro R. Advances in Purification, Modification, and Application of Extracellular Vesicles for Novel Clinical Treatments. Membranes (Basel) 2022;12. [PMID: 36557150 DOI: 10.3390/membranes12121244] [Reference Citation Analysis]